BMI Doctors offers two injectable medication options through its telemedicine platform: Injectable Semaglutide at $249 per month is the primary pricing offer listed, while Injectable Tirzepatide is available at $330 per month. Both medications are prescribed through BMI Doctors's specialist telemedicine service, backed by Ocenture's 25 years of experience serving employers and municipalities. Your choice depends on which medication your doctor recommends and your budget for ongoing treatment.
Choosing between medications: Semaglutide versus Tirzepatide. The key difference between these offers is the medication and the monthly cost. Injectable Semaglutide at $249 per month is the less expensive option and may be the right choice if your doctor prescribes it or if budget is a primary concern. Injectable Tirzepatide at $330 per month costs $81 more per month, or roughly $972 more per year, and is prescribed when clinical outcomes or your medical history suggest it is the better fit. Both medications are subject to availability and require a telemedicine consultation with a BMI Doctors doctor to confirm eligibility and appropriate dosing.
When making your decision, work with your healthcare provider to determine which medication is medically suitable for your situation. Once your doctor recommends a specific injectable, the pricing is straightforward: Semaglutide runs $249 monthly and Tirzepatide runs $330 monthly. If both medications are clinically appropriate for you, the Semaglutide option will save you $972 per year compared to Tirzepatide. Confirm current availability and any additional consultation or setup fees by visiting the BMI Doctors website, as both offers are subject to availability and full terms apply.